Komori
Qol Holdings (3034) · RiskMaterialised

Impact of Disasters, Epidemics and Other Events on Store Operations

First written in FY2016. 6 of 16 entries say "Materialised", first in FY2020. Latest entry: FY2024.

16entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY20172016: 120162017: 120172018: 020182019: 020192020: 320202021: 420212022: 420222023: 220232024: 12024
Same theme, other companies
Risk of Store and Logistics Network Disruptions Due to Natural DisastersA theme 83 companies write about · 80 as a headwind · 5 as a tailwind

Qol Holdings moved to the "Worse" side of this theme in 2020, 1 year before the typical company in this theme (2021).

The whole theme swung hardest in 2026: 15 of 31 companies on the "Worse" side.

16 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 83 companies compared. The sentences above are computed from all 83.
Full recordFilings, disclosures and news, newest first
  1. FY2024MaterialisedAnnual report

    「In the Reiwa 6 Noto Peninsula Earthquake that occurred in January 2024, no employees suffered personal injury. However, 3 stores in Ishikawa Prefecture sustained significant damage requiring temporary closure. The company dispatched approximately 70 employees from across Japan and worked to provide safe and secure medical care, prioritizing the continuity of medical services. At QOL Notocho Pharmacy, water outages continued and reopening took time, so the company opened a temporary store at Noto Town Matsunami Junior High School after confirming the arrangement with the local authorities.」

    Disaster risk materialized in the form of the Reiwa 6 Noto Peninsula Earthquake, affecting 3 stores in Ishikawa Prefecture. The company responded by dispatching approximately 70 employees and opening a temporary store to maintain medical services.
  2. FY2024-Q1MitigatedAnnual report

    「In the dispensing pharmacy industry, the effects of patients refraining from visiting medical institutions and the curtailment of outpatient services have eased as the number of COVID-19 infections has declined.」

    The company reported that the effects on the dispensing pharmacy industry of patients refraining from seeking medical care and curtailed outpatient services had eased as the number of COVID-19 infections declined.
  3. FY2023-Q3WorsenedAnnual report

    「During the third quarter of the fiscal year, the outlook remained uncertain due to the spread of the eighth wave of COVID-19, soaring energy prices, rising prices and other factors.」

    The company reported the spread of the eighth wave following the seventh wave, and indicated that the outlook remained uncertain due to COVID-19.
  4. FY2023-Q2WorsenedAnnual report

    「At the same time, the situation remains unpredictable, as the seventh wave of COVID-19 caused a sharp increase in infections, leading to renewed increases in patients refraining from seeking medical care and restrictions on outpatient services at medical institutions.」

    After a move toward normalization following the easing of restrictions on activities and other measures, the number of infections surged during the seventh wave, and patients again increasingly refrained from seeking medical care while outpatient services were curtailed.
  5. FY2023-Q1MitigatedAnnual report

    「In the dispensing pharmacy industry, there were signs of a move toward normalization of economic activity, including the easing of restrictions on activities as the number of new COVID-19 infections declined. However, the effects of patients refraining from visiting medical institutions and the curtailment of outpatient services due to the spread of COVID-19 have continued to some extent.」

    While the decline in new infections and easing of restrictions on activities have produced signs of normalization, the effects of patients refraining from seeking medical care and curtailed outpatient services have continued to some extent.
  6. FY2022RestatedAnnual report

    「In the Insurance Pharmacy Business, the effects of patients refraining from visiting medical institutions and the curtailment of outpatient services are expected to continue to some extent due to COVID-19. The timing of the end of the COVID-19 pandemic remains uncertain, and changes in its impact on the economic environment may affect the Group's performance.」

    The company expects the effects of patients refraining from seeking medical care and curtailed outpatient services to continue to some extent, and continues to indicate uncertainty regarding when the pandemic will end and its economic impact.
  7. FY2022-Q3WorsenedAnnual report

    「In Japan, the spread of COVID-19 vaccination led to a decline in new infections and signs of a gradual recovery. However, infections caused by the highly transmissible Omicron variant increased, making the outlook uncertain again.」

    The company reported signs of recovery due to the spread of vaccination and a decline in new infections, while indicating that the outlook had become uncertain again as infections caused by the Omicron variant increased.
  8. FY2022-Q2MitigatedAnnual report

    「The dispensing pharmacy industry remains in a difficult environment, affected by patients refraining from visiting medical institutions and the curtailment of outpatient services due to the spread of COVID-19. However, there are signs of a gradual recovery, including a decline in the number of new infections as COVID-19 vaccination has become more widespread.」

    While the difficult conditions caused by patients refraining from seeking medical care and curtailed outpatient services have continued, the spread of vaccination and decline in new infections have produced signs of a gradual recovery.
  9. FY2022-Q1RestatedAnnual report

    「The dispensing pharmacy industry remains in a difficult environment, affected by patients refraining from visiting medical institutions and the curtailment of outpatient services due to the spread of COVID-19.」

    The difficult conditions in the dispensing pharmacy industry due to patients refraining from seeking medical care and the curtailment of outpatient services have continued.
  10. FY2021MaterialisedAnnual report

    「In the Insurance Pharmacy Business, the number of prescriptions has declined due to COVID-19, as patients have refrained from visiting medical institutions, outpatient services at medical institutions have been curtailed, and prescription durations have been extended.」

    The effects of COVID-19, including patients refraining from seeking medical care, curtailed outpatient services, longer prescription durations and a decline in prescription volumes, have continued throughout the fiscal year.
  11. FY2021-Q3MaterialisedAnnual report

    「The dispensing pharmacy industry remains in a difficult environment, affected by a decline in the number of visits as patients refrain from visiting medical institutions and outpatient services are curtailed due to the spread of COVID-19.」

    The effects of COVID-19, including patients refraining from seeking medical care, curtailed outpatient services and a decline in the number of visits, have continued.
  12. FY2021-Q2MaterialisedAnnual report

    「The dispensing pharmacy industry remains in a difficult environment, affected by a decline in the number of visits as patients refrain from visiting medical institutions and outpatient services are curtailed due to the spread of COVID-19.」

    The difficult conditions in the dispensing pharmacy industry have continued, with COVID-19 continuing to cause patients to refrain from seeking medical care, outpatient services to be curtailed and the number of visits to decline.
  13. FY2021-Q1MaterialisedAnnual report

    「The dispensing pharmacy industry remains in a difficult environment, including a decline in the number of patient visits and other effects of the spread of COVID-19, as patients have refrained from visiting medical institutions and outpatient services have been curtailed. At the same time, measures such as the use of online medication guidance are being rapidly promoted to ensure the continued provision of medical care and to respond to changes in lifestyles.」

    COVID-19 has caused patients to refrain from seeking medical care, outpatient services to be curtailed and the number of visits to decline. Measures such as online medication guidance are also being promoted.
  14. FY2020MaterialisedAnnual report

    「In the Insurance Pharmacy Business, the number of prescriptions has declined due to COVID-19, as patients have refrained from visiting medical institutions, outpatient services at medical institutions have been curtailed, and prescription durations have been extended. If infections spread further or persist for an extended period, the Group's performance may be affected.」

    The previously recognized epidemic risk materialized as COVID-19, and the company reported a decline in prescription volumes due to patients refraining from seeking medical care and other factors.
  15. FY2017RestatedAnnual report

    「If an unforeseen fire, terrorist attack, war, epidemic, earthquake, extreme weather event or other incident occurs in the regions where the Group operates and causes damage to stores, suspends product supplies to stores or otherwise prevents stores from continuing operations, the Group's performance and other factors may be affected.」

    The risks of store damage, supply disruptions and difficulty continuing operations due to disasters, epidemics and other events remain present.
  16. FY2016First statedAnnual report

    「If an unforeseen man-made disaster, such as a fire, terrorist attack, war or epidemic, or a natural disaster, such as an earthquake or extreme weather, causes damage to stores, suspends product supplies to stores or otherwise prevents stores from continuing operations, the Group's business operations, performance and financial condition may be affected.」

    Business continuity risks, including store damage, supply disruptions and difficulty continuing operations.
Moved together

"Revenue and Profit Growth" moved the same way as this thread, in the same document, in 8 of its 16 moves.

853322★123456
  1. ★This thread
  2. 1Revenue and Profit Growth8×
  3. 2Goodwill Impairment Associated with M&A5×
  4. 3Business Expansion through M&A3×
  5. 4Strengthening Customer Acquisition and Analytics Functions and Expanding Target Occupations in the Staffing and Recruitment Business3×
  6. 5Expansion of Store Count, Including Acquisitions2×
  7. 6Enhancing Home Healthcare and Regional Healthcare Coordination2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Qol Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of Disasters, Epidemics and Other Events on Store Operations | Qol Holdings Co.,Ltd. (3034) | Komori